1. Home
  2. ELDN vs MPAA Comparison

ELDN vs MPAA Comparison

Compare ELDN & MPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$1.97

Market Cap

219.4M

Sector

Health Care

ML Signal

HOLD

Logo Motorcar Parts  of America Inc.

MPAA

Motorcar Parts of America Inc.

HOLD

Current Price

$7.43

Market Cap

202.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELDN
MPAA
Founded
2004
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
219.4M
202.6M
IPO Year
2014
2007

Fundamental Metrics

Financial Performance
Metric
ELDN
MPAA
Price
$1.97
$7.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
$9.00
★ $17.33
AVG Volume (30 Days)
★ 918.4K
107.1K
Earning Date
11-12-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
30.67
★ 162.63
EPS
★ N/A
N/A
Revenue
N/A
★ $789,806,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.75
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 4.28
52 Week Low
$1.35
$7.24
52 Week High
$4.49
$16.43

Technical Indicators

Market Signals
Indicator
ELDN
MPAA
Relative Strength Index (RSI) 35.64 24.25
Support Level N/A $7.24
Resistance Level $3.14 $11.07
Average True Range (ATR) 0.27 0.50
MACD -0.07 -0.24
Stochastic Oscillator 3.83 3.99

Price Performance

Historical Comparison
ELDN
MPAA

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

About MPAA Motorcar Parts of America Inc.

Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts, test solutions, and diagnostic equipment. Its replacement parts are mainly sold to automotive retail chain stores, warehouse distributors across North America, and automobile manufacturers for aftermarket and warranty replacement programs. The Company's test solutions and diagnostic equipment serve the automotive component and powertrain testing market. Its product portfolio includes rotating electrical products such as alternators and starters; brake-related products including brake calipers, brake rotors, brake pads, brake master cylinders, and wheel hub assemblies and bearings; and other products. Its segments are Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty.

Share on Social Networks: